[Val5]-Angiotensin II acetate salt hydrate
SIGMA/A2900 - ≥95% (HPLC), powder
Empirical Formula (Hill Notation): C49H69N13O12 · xC2H4O2 · yH2O
Molecular Weight: 1032.15 (anhydrous free base basis)
Linear Formula: C49H69N13O12 · xC2H4O2 · yH2O
Product Type: Chemical
assay | ≥95% (HPLC) |
composition | acetate, 1.2-10.4% |
form | powder |
InChI | 1S/C49H69N13O12.C2H4O2.H2 |
InChI key | INQPQDZJLFYCRH-AXOAQIBVSA |
Quality Level | 200 |
SMILES string | O.CC(O)=O.CC(C)[C@H](NC(= |
storage temp. | −20°C |
Amino Acid Sequence: | Asp-Arg-Val-Tyr-Val-His-P |
Application: | [Val5]-Angiotensin II acetate salt hydrate has been used to induce: • renal damage in mice to study the role of human liver-type fatty acid-binding protein (hL-FABP) • vascular inflammation in mice to study the interaction of cytosolic copper chaperone antioxidant-1 (Atox1) with tumor necrosis factor (TNF)-receptor-associated factor 4 (TRAF4) • abdominal aortic aneurysm (AAA) in mice to study the role of vascular ATPase copper transporting α (ATP7 |
Biochem/physiol Actions: | [Val5]-Angiotensin II acts as an agonist for the angiotensin II type 1 receptor (AT1 receptor). |
General description: | [Val5]-Angiotensin II ([Val5]-ANG II) is an ANG II analog containing valine as the fifth amino acid in place of isoleucine in an ANG II octapeptide. |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥95% (HPLC) |
Storage Temp. | −20°C |
UNSPSC | 12352209 |